AMD-derived RPE has been shown to exhibit increased expression of PARP2 (poly (ADP-ribose) polymerase 2), resulting in decreased NAD+ levels and a significant reduction in SIRT1 protein levels in the RPE of affected donors compared to normal RPE. The gene discussed is SIRT1; the disease is age-related macular degeneration.